BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11428925)

  • 1. Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.
    Simoni D; Roberti M; Invidiata FP; Rondanin R; Baruchello R; Malagutti C; Mazzali A; Rossi M; Grimaudo S; Capone F; Dusonchet L; Meli M; Raimondi MV; Landino M; D'Alessandro N; Tolomeo M; Arindam D; Lu S; Benbrook DM
    J Med Chem; 2001 Jul; 44(14):2308-18. PubMed ID: 11428925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells.
    Simoni D; Roberti M; Invidiata FP; Rondanin R; Baruchello R; Malagutti C; Mazzali A; Rossi M; Grimaudo S; Dusonchet L; Meli M; Raimondi MV; D'Alessandro N; Tolomeo M
    Bioorg Med Chem Lett; 2000 Dec; 10(23):2669-73. PubMed ID: 11128648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of novel heteroretinoids: induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid.
    Simoni D; Invidiata FP; Rondanin R; Grimaudo S; Cannizzo G; Barbusca E; Porretto F; D'Alessandro N; Tolomeo M
    J Med Chem; 1999 Dec; 42(24):4961-9. PubMed ID: 10585206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines.
    Simoni D; Grisolia G; Giannini G; Roberti M; Rondanin R; Piccagli L; Baruchello R; Rossi M; Romagnoli R; Invidiata FP; Grimaudo S; Jung MK; Hamel E; Gebbia N; Crosta L; Abbadessa V; Di Cristina A; Dusonchet L; Meli M; Tolomeo M
    J Med Chem; 2005 Feb; 48(3):723-36. PubMed ID: 15689156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
    Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
    Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines.
    Nagy L; Thomázy VA; Shipley GL; Fésüs L; Lamph W; Heyman RA; Chandraratna RA; Davies PJ
    Mol Cell Biol; 1995 Jul; 15(7):3540-51. PubMed ID: 7791761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel atypical retinoid endowed with proapoptotic and antitumor activity.
    Cincinelli R; Dallavalle S; Merlini L; Penco S; Pisano C; Carminati P; Giannini G; Vesci L; Gaetano C; Illy B; Zuco V; Supino R; Zunino F
    J Med Chem; 2003 Mar; 46(6):909-12. PubMed ID: 12620066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
    Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoids, apoptosis and cancer.
    Simoni D; Tolomeo M
    Curr Pharm Des; 2001 Nov; 7(17):1823-37. PubMed ID: 11562311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
    Zacheis D; Dhar A; Lu S; Madler MM; Klucik J; Brown CW; Liu S; Clement F; Subramanian S; Weerasekare GM; Berlin KD; Gold MA; Houck JR; Fountain KR; Benbrook DM
    J Med Chem; 1999 Oct; 42(21):4434-45. PubMed ID: 10543887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha.
    Szondy Z; Reichert U; Bernardon JM; Michel S; Tóth R; Karászi E; Fésüs L
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):767-74. PubMed ID: 9560303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.
    Dhar A; Liu S; Klucik J; Berlin KD; Madler MM; Lu S; Ivey RT; Zacheis D; Brown CW; Nelson EC; Birckbichler PJ; Benbrook DM
    J Med Chem; 1999 Sep; 42(18):3602-14. PubMed ID: 10479291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma.
    Guruswamy S; Lightfoot S; Gold MA; Hassan R; Berlin KD; Ivey RT; Benbrook DM
    J Natl Cancer Inst; 2001 Apr; 93(7):516-25. PubMed ID: 11287445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
    Wan H; Dawson MI; Hong WK; Lotan R
    Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
    Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
    Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM; Offterdinger M; Huber H; Grunt TW
    Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinobenzoic acids. 6. Retinoid antagonists with a heterocyclic ring.
    Eyrolles L; Kagechika H; Kawachi E; Fukasawa H; Iijima T; Matsushima Y; Hashimoto Y; Shudo K
    J Med Chem; 1994 May; 37(10):1508-17. PubMed ID: 8182710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
    Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A
    Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New isoxazole derivatives of retinoids: synthesis and activity on growth and differentiation of tumor cells.
    Simoni D; Manfredini S; Tabrizi MA; Bazzanini R; Baraldi PG; Ferroni R; Traniello F; Nastruzzi C; Feriotto G; Gambari R
    Drug Des Discov; 1992 Feb; 8(3):165-77. PubMed ID: 1525301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.